STOP WEIRD Act of 2024

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9586 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 9586

  To prohibit Federal funds from being used to provide certain gender 
 transition procedures to individuals in the custody of the Department 
 of Homeland Security and the Department of Health and Human Services.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 12, 2024

  Mr. Steube (for himself, Mr. Reschenthaler, Mr. Weber of Texas, Mr. 
  Duncan, Mr. LaMalfa, Mr. Tiffany, and Mr. Rosendale) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on the Judiciary, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
  To prohibit Federal funds from being used to provide certain gender 
 transition procedures to individuals in the custody of the Department 
 of Homeland Security and the Department of Health and Human Services.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stopping Transgender Operation 
Payments and Wacky Expenses for Illegal Residents and Detainees Act of 
2024'' or the ``STOP WEIRD Act of 2024''.

SEC. 2. PROHIBITING FEDERAL FUNDS FROM BEING USED TO PROVIDE CERTAIN 
              GENDER TRANSITION PROCEDURES.

    (a) In General.--Notwithstanding any other provision of law, no 
Federal funds may be used or otherwise made available to provide or 
refer for a specified gender transition procedure to an individual in 
the custody of the Department of Homeland Security or the Department of 
Health and Human Services or to reimburse any entity for providing such 
a procedure to such an individual.
    (b) Specified Gender Transition Procedure Defined.--
            (1) In general.--For purposes of this paragraph, except as 
        provided in paragraph (2), the term ``specified gender 
        transition procedure'' means, with respect to an individual, 
        any of the following when performed for the purpose of 
        intentionally changing the body of such individual to no longer 
        correspond to their sex:
                    (A) Performing any surgery, including--
                            (i) castration;
                            (ii) orchiectomy;
                            (iii) scrotoplasty;
                            (iv) vasectomy;
                            (v) hysterectomy;
                            (vi) oophorectomy;
                            (vii) ovariectomy;
                            (viii) metoidioplasty;
                            (ix) penectomy;
                            (x) phalloplasty;
                            (xi) vaginoplasty;
                            (xii) vaginectomy;
                            (xiii) vulvoplasty;
                            (xiv) reduction thyrochondroplasty;
                            (xv) chondrolaryngoplasty;
                            (xvi) mastectomy; and
                            (xvii) any plastic, cosmetic, or aesthetic 
                        surgery that feminizes or masculinizes the 
                        facial or other body features of an individual.
                    (B) Any placement of chest implants to create 
                feminine breasts.
                    (C) Any placement of fat or artificial implants in 
                the gluteal region.
                    (D) Administering, supplying, prescribing, 
                dispensing, distributing, or otherwise conveying to an 
                individual medications, including--
                            (i) gonadotropin-releasing hormone (GnRH) 
                        analogues or other puberty-blocking drugs to 
                        stop or delay normal puberty; and
                            (ii) testosterone, estrogen, or other 
                        androgens to an individual at doses that are 
                        supraphysiologic than would normally be 
                        produced endogenously in a healthy individual 
                        of the same age and sex.
            (2) Sex.--For purposes of paragraph (1), the term ``sex'' 
        means the indication of male or female sex by reproductive 
        potential or capacity, sex chromosomes, naturally occurring sex 
        hormones, gonads, or internal or external genitalia present at 
        birth.
                                 <all>